1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Melanoma Diagnostics and Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Nodular Melanoma 1.4.3 Superficial Spreading Melanoma 1.4.4 Amelanotic Melanoma 1.4.5 Others 1.5 Market by Application 1.5.1 Global Melanoma Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Diagnostic Center 1.5.4 Medical Institution 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Melanoma Diagnostics and Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Melanoma Diagnostics and Therapeutics Industry 1.6.1.1 Melanoma Diagnostics and Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Melanoma Diagnostics and Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Melanoma Diagnostics and Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Melanoma Diagnostics and Therapeutics Market Perspective (2015-2026) 2.2 Melanoma Diagnostics and Therapeutics Growth Trends by Regions 2.2.1 Melanoma Diagnostics and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Melanoma Diagnostics and Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Melanoma Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Melanoma Diagnostics and Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Melanoma Diagnostics and Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Melanoma Diagnostics and Therapeutics Players by Market Size 3.1.1 Global Top Melanoma Diagnostics and Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Melanoma Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio 3.2.1 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Melanoma Diagnostics and Therapeutics Revenue in 2019 3.3 Melanoma Diagnostics and Therapeutics Key Players Head office and Area Served 3.4 Key Players Melanoma Diagnostics and Therapeutics Product Solution and Service 3.5 Date of Enter into Melanoma Diagnostics and Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Melanoma Diagnostics and Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Type (2021-2026) 5 Melanoma Diagnostics and Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) 5.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Melanoma Diagnostics and Therapeutics Market Size (2015-2020) 6.2 Melanoma Diagnostics and Therapeutics Key Players in North America (2019-2020) 6.3 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) 6.4 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Melanoma Diagnostics and Therapeutics Market Size (2015-2020) 7.2 Melanoma Diagnostics and Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) 7.4 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size (2015-2020) 8.2 Melanoma Diagnostics and Therapeutics Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) 8.4 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Abbott 9.1.1 Abbott Company Details 9.1.2 Abbott Business Overview and Its Total Revenue 9.1.3 Abbott Melanoma Diagnostics and Therapeutics Introduction 9.1.4 Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020)) 9.1.5 Abbott Recent Development 9.2 Agilent Technologies 9.2.1 Agilent Technologies Company Details 9.2.2 Agilent Technologies Business Overview and Its Total Revenue 9.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Introduction 9.2.4 Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.2.5 Agilent Technologies Recent Development 9.3 AstraZeneca 9.3.1 AstraZeneca Company Details 9.3.2 AstraZeneca Business Overview and Its Total Revenue 9.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Introduction 9.3.4 AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.3.5 AstraZeneca Recent Development 9.4 Bristol-Myers Squibb 9.4.1 Bristol-Myers Squibb Company Details 9.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 9.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Introduction 9.4.4 Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.4.5 Bristol-Myers Squibb Recent Development 9.5 Eli Lilly 9.5.1 Eli Lilly Company Details 9.5.2 Eli Lilly Business Overview and Its Total Revenue 9.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Introduction 9.5.4 Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.5.5 Eli Lilly Recent Development 9.6 GlaxoSmithKline 9.6.1 GlaxoSmithKline Company Details 9.6.2 GlaxoSmithKline Business Overview and Its Total Revenue 9.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Introduction 9.6.4 GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.6.5 GlaxoSmithKline Recent Development 9.7 Merck 9.7.1 Merck Company Details 9.7.2 Merck Business Overview and Its Total Revenue 9.7.3 Merck Melanoma Diagnostics and Therapeutics Introduction 9.7.4 Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.7.5 Merck Recent Development 9.8 Novartis 9.8.1 Novartis Company Details 9.8.2 Novartis Business Overview and Its Total Revenue 9.8.3 Novartis Melanoma Diagnostics and Therapeutics Introduction 9.8.4 Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.8.5 Novartis Recent Development 9.9 Pfizer 9.9.1 Pfizer Company Details 9.9.2 Pfizer Business Overview and Its Total Revenue 9.9.3 Pfizer Melanoma Diagnostics and Therapeutics Introduction 9.9.4 Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.9.5 Pfizer Recent Development 9.10 Qiagen 9.10.1 Qiagen Company Details 9.10.2 Qiagen Business Overview and Its Total Revenue 9.10.3 Qiagen Melanoma Diagnostics and Therapeutics Introduction 9.10.4 Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 9.10.5 Qiagen Recent Development 9.11 Roche 10.11.1 Roche Company Details 10.11.2 Roche Business Overview and Its Total Revenue 10.11.3 Roche Melanoma Diagnostics and Therapeutics Introduction 10.11.4 Roche Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 10.11.5 Roche Recent Development 9.12 Sanofi 10.12.1 Sanofi Company Details 10.12.2 Sanofi Business Overview and Its Total Revenue 10.12.3 Sanofi Melanoma Diagnostics and Therapeutics Introduction 10.12.4 Sanofi Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) 10.12.5 Sanofi Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Melanoma Diagnostics and Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Melanoma Diagnostics and Therapeutics Revenue Table 3. Ranking of Global Top Melanoma Diagnostics and Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Nodular Melanoma Table 6. Key Players of Superficial Spreading Melanoma Table 7. Key Players of Amelanotic Melanoma Table 8. Key Players of Others Table 9. COVID-19 Impact Global Market: (Four Melanoma Diagnostics and Therapeutics Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Melanoma Diagnostics and Therapeutics Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Melanoma Diagnostics and Therapeutics Players to Combat Covid-19 Impact Table 14. Global Melanoma Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Melanoma Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Melanoma Diagnostics and Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2015-2020) Table 18. Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Melanoma Diagnostics and Therapeutics Market Growth Strategy Table 24. Main Points Interviewed from Key Melanoma Diagnostics and Therapeutics Players Table 25. Global Melanoma Diagnostics and Therapeutics Revenue by Players (2015-2020) (Million US$) Table 26. Global Melanoma Diagnostics and Therapeutics Market Share by Players (2015-2020) Table 27. Global Top Melanoma Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Diagnostics and Therapeutics as of 2019) Table 28. Global Melanoma Diagnostics and Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Melanoma Diagnostics and Therapeutics Product Solution and Service Table 31. Date of Enter into Melanoma Diagnostics and Therapeutics Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 34. Global Melanoma Diagnostics and Therapeutics Market Size Share by Type (2015-2020) Table 35. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Type (2021-2026) Table 36. Global Melanoma Diagnostics and Therapeutics Market Size Share by Application (2015-2020) Table 37. Global Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. Global Melanoma Diagnostics and Therapeutics Market Size Share by Application (2021-2026) Table 39. North America Key Players Melanoma Diagnostics and Therapeutics Revenue (2019-2020) (Million US$) Table 40. North America Key Players Melanoma Diagnostics and Therapeutics Market Share (2019-2020) Table 41. North America Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. North America Melanoma Diagnostics and Therapeutics Market Share by Type (2015-2020) Table 43. North America Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. North America Melanoma Diagnostics and Therapeutics Market Share by Application (2015-2020) Table 45. Europe Key Players Melanoma Diagnostics and Therapeutics Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Melanoma Diagnostics and Therapeutics Market Share (2019-2020) Table 47. Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. Europe Melanoma Diagnostics and Therapeutics Market Share by Type (2015-2020) Table 49. Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. Europe Melanoma Diagnostics and Therapeutics Market Share by Application (2015-2020) Table 51. Asia-Pacific Key Players Melanoma Diagnostics and Therapeutics Revenue (2019-2020) (Million US$) Table 52. Asia-Pacific Key Players Melanoma Diagnostics and Therapeutics Market Share (2019-2020) Table 53. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Type (2015-2020) Table 55. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Application (2015-2020) Table 57. Abbott Company Details Table 58. Abbott Business Overview Table 59. Abbott Product Table 60. Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 61. Abbott Recent Development Table 62. Agilent Technologies Company Details Table 63. Agilent Technologies Business Overview Table 64. Agilent Technologies Product Table 65. Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 66. Agilent Technologies Recent Development Table 67. AstraZeneca Company Details Table 68. AstraZeneca Business Overview Table 69. AstraZeneca Product Table 70. AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 71. AstraZeneca Recent Development Table 72. Bristol-Myers Squibb Company Details Table 73. Bristol-Myers Squibb Business Overview Table 74. Bristol-Myers Squibb Product Table 75. Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 76. Bristol-Myers Squibb Recent Development Table 77. Eli Lilly Company Details Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Product Table 80. Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 81. Eli Lilly Recent Development Table 82. GlaxoSmithKline Company Details Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Product Table 85. GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 86. GlaxoSmithKline Recent Development Table 87. Merck Company Details Table 88. Merck Business Overview Table 89. Merck Product Table 90. Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 91. Merck Recent Development Table 92. Novartis Business Overview Table 93. Novartis Product Table 94. Novartis Company Details Table 95. Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 96. Novartis Recent Development Table 97. Pfizer Company Details Table 98. Pfizer Business Overview Table 99. Pfizer Product Table 100. Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 101. Pfizer Recent Development Table 102. Qiagen Company Details Table 103. Qiagen Business Overview Table 104. Qiagen Product Table 105. Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 106. Qiagen Recent Development Table 107. Roche Company Details Table 108. Roche Business Overview Table 109. Roche Product Table 110. Roche Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 111. Roche Recent Development Table 112. Sanofi Company Details Table 113. Sanofi Business Overview Table 114. Sanofi Product Table 115. Sanofi Revenue in Melanoma Diagnostics and Therapeutics Business (2015-2020) (Million US$) Table 116. Sanofi Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Melanoma Diagnostics and Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Nodular Melanoma Features Figure 3. Superficial Spreading Melanoma Features Figure 4. Amelanotic Melanoma Features Figure 5. Others Features Figure 6. Global Melanoma Diagnostics and Therapeutics Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Diagnostic Center Case Studies Figure 9. Medical Institution Case Studies Figure 10. Others Case Studies Figure 11. Melanoma Diagnostics and Therapeutics Report Years Considered Figure 12. Global Melanoma Diagnostics and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Melanoma Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2026 Figure 14. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Melanoma Diagnostics and Therapeutics Market Share by Players in 2019 Figure 17. Global Top Melanoma Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Diagnostics and Therapeutics as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Melanoma Diagnostics and Therapeutics Revenue in 2019 Figure 19. North America Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Abbott Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 24. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Agilent Technologies Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 26. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. AstraZeneca Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 28. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 30. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Eli Lilly Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. GlaxoSmithKline Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 34. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Merck Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Novartis Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Pfizer Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 40. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Qiagen Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 42. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Roche Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 44. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Sanofi Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Abbott Agilent Technologies AstraZeneca Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Merck Novartis Pfizer Qiagen Roche Sanofi